News | etectRx

Breakthrough ID-Cap System from etectRx™ Selected to Measure Adherence to HIV Treatment in New University of Colorado Study

1/7/2020

Announcement coincides with the issuance of two new U.S. Patents GAINESVILLE, Fla. (January 12, 2020) – etectRx™, Inc. (etectRx™), a privately-held digital health company, today...

Future Proof Pharmacy with Harry Travis – Pharmacy Podcast Nation

12/30/2019

The original host of the Specialty Pharmacy Podcast and a frequent guest on the Pharmacy Podcast Network, Harry Travis, etectRx President & CEO, joins Todd Eury...

etectRx Announces U.S. FDA Clearance of Novel Ingestible Event Marker

12/9/2019

ID-Cap System Uses Advanced Wireless Technology to Reliably Track Ingestion Events GAINESVILLE, Fla. (December 9, 2019) – etectRx®, Inc. (etectRx), a privately-held digital health company,...

Formative Qualitative Response of MSM with Substance Use to Digital Pills for PrEP Adherence

6/19/2019

Formative qualitative response of MSM with substance use to digital pills for PrEP adherence

Technology You Ingest: Interview with Harry Travis

6/12/2019

Harry Travis, president & CEO of etectRx, interviewed with the Orlando Entrepreneurs podcast to share the company story. Listen here at https://www.orlandoentrepreneurs.org/technology-you-ingest-interview-with-harry-travis/

etectRx, Inc. Announces Issuance of Additional U.S. Patents for Ingestible Medication Adherence System

6/10/2019

GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued...

Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills

6/8/2019

Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills

etectRx and Qualicaps Extend Strategic Relationship to Develop ID-Cap Technologies and Digital Pharma Market Opportunities

6/6/2019

Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to...

Digital Pills May Be on the Horizon in Cancer Care

3/8/2019

CEO of etectRx, Harry Travis, spoke with Oncology Live about digital pills, like the ID-Capsule, as a possibility for improving cancer care. Read more at https://www.onclive.com/publications/Oncology-live/2019/vol-20-no-5/digital-pills-may-be-on-the-horizon-in-cancer-care?p=1

etectRx’s Innovative ID-Cap System Selected to Track Medication Ingestion in HIV Prevention Study

3/4/2019

Digital Medicine System has the potential to provide clinicians with a new tool to track and manage adherence for HIV prevention therapy GAINESVILLE, Fla. (March...

Guardian angel or watchdog? Pills of capecitabine contain sensors

2/8/2019

CEO of etectRx, Harry Travis, spoke with MDedge about the future of digital medicine and how our state-of-the-art ID-Cap system can impact the medical industry. Read more...

etectRx Officially Moves into the University of Florida’s Innovation Hub

2/26/2018

We are proud to announce that etectRx has officially moved into the UF Innovation Hub’s ultra-modern facilities, providing our team the additional lab and office...